Performance of neoadjuvant therapy in locally advanced adenocarcinoma of the pancreas: A single large volume center experience.

e16745Background: Pancreatic adenocarcinoma (PC) is a disease with low 5-year survival rates even in patients who undergo surgical resection: ~10% overall and 20-35% in those with negative lymph no...